High materiality7/10
Revolution Medicines price target raised to $251 from $203 at RBC Capital
Why it may matterVerify against the original reporting
bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RVMD target raised to $251; current price $220.82; priceChangeSinceSignal -1.51.
- Target up to $251; price $220.82.
Key facts
- 01
Target: $251
- 02
Posted price: $220.82
- 03
Analyst firm: RBC Capital
- 04
Analyst: Leonid Timashev
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.